Joseph C. Papa
2017 - Valeant Pharmaceuticals International
In 2017, Joseph C. Papa earned a total compensation of $4.9M as Chief Executive Officer at Valeant Pharmaceuticals International, a 92% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,981,250 |
|---|---|
| Salary | $1,500,000 |
| Other | $413,858 |
| Total | $4,895,108 |
Papa received $3M in non-equity incentive plan, accounting for 61% of the total pay in 2017.
Papa also received $1.5M in salary and $413.9K in other compensation.
Rankings
In 2017, Joseph C. Papa's compensation ranked 1,937th out of 14,666 executives tracked by ExecPay. In other words, Papa earned more than 86.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,937 out of 14,666 | 87th |
Division Manufacturing | 660 out of 5,772 | 89th |
Major group Chemicals And Allied Products | 174 out of 2,075 | 92nd |
Industry group Drugs | 129 out of 1,731 | 93rd |
Industry Pharmaceutical Preparations | 98 out of 1,333 | 93rd |
Source: SEC filing on March 21, 2018.
Papa's colleagues
We found four more compensation records of executives who worked with Joseph C. Papa at Valeant Pharmaceuticals International in 2017.
2017
William Humphries
Valeant Pharmaceuticals International
Group Chairman
2017
Thomas Appio
Valeant Pharmaceuticals International
Group Chairman
2017
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2017
Paul Herendeen
Valeant Pharmaceuticals International